Abstract
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference10 articles.
1. A case-control study of the clinical diagnosis and course of Lassa fever;JB McCormick;J Infect Dis,1987
2. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019;CC Dan-Nwafor;Euro Surveill,2019
3. Use of Favipiravir to Treat Lassa Virus Infection in Macaques;K Rosenke;Emerg Infect Dis,2018
4. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever;CE Mire;Nat Med,2017
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献